(lp0
(dp1
S'contVal'
p2
NsS'drug2'
p3
Vhttp://bio2rdf.org/drugbank:DB01104
p4
sS'drug1'
p5
Vhttp://bio2rdf.org/drugbank:DB00476
p6
sS'objectUri'
p7
NsS'evidence'
p8
NsS'ddiPkMechanism'
p9
NsS'whoAnnotated'
p10
NsS'contraindication'
p11
NsS'researchStatementLabel'
p12
NsS'severity'
p13
NsS'label'
p14
Vsertraline is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
p15
sS'effectConcept'
p16
NsS'source'
p17
S'DIKB'
p18
sS'ddiPkEffect'
p19
NsS'homepage'
p20
NsS'pathway'
p21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p22
sS'ddiType'
p23
NsS'researchStatement'
p24
NsS'dateAnnotated'
p25
NsS'object'
p26
Vduloxetine
p27
sS'evidenceSource'
p28
NsS'evidenceStatement'
p29
NsS'precipUri'
p30
NsS'certainty'
p31
NsS'uri'
p32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/122
p33
sS'evidenceType'
p34
NsS'numericVal'
p35
NsS'precaution'
p36
NsS'precipitant'
p37
Vsertraline
p38
sa(dp39
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p40
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p41
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p42
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p43
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p44
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/123
p45
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p46
sa(dp47
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p48
sg5
Vhttp://bio2rdf.org/drugbank:DB00472
p49
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
p50
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p51
sg23
Nsg24
Nsg25
Nsg26
Vfluoxetine
p52
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/124
p53
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p54
sa(dp55
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p56
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p57
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p58
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p59
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p60
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/125
p61
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p62
sa(dp63
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p64
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p65
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p66
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p67
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p68
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/126
p69
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p70
sa(dp71
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p72
sg5
Vhttp://bio2rdf.org/drugbank:DB00715
p73
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
p74
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p75
sg23
Nsg24
Nsg25
Nsg26
Vparoxetine
p76
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/127
p77
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p78
sa(dp79
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p80
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p81
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
p82
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p83
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p84
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/128
p85
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p86
sa(dp87
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p88
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p89
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p90
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p91
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p92
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/267
p93
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p94
sa(dp95
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p96
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p97
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p98
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p99
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p100
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/458
p101
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p102
sa(dp103
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p104
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p105
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p106
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p107
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p108
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/459
p109
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p110
sa(dp111
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p112
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p113
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p114
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p115
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p116
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/461
p117
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p118
sa(dp119
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p120
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p121
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p122
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p123
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p124
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/462
p125
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p126
sa(dp127
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p128
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p129
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p130
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p131
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p132
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/602
p133
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p134
sa(dp135
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01104
p136
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p137
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vsertraline is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p138
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p139
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p140
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/603
p141
sg34
Nsg35
Nsg36
Nsg37
Vsertraline
p142
sa(dp143
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00745
p144
sg5
Vhttp://bio2rdf.org/drugbank:DB00215
p145
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vmodafinil is predicted to reduce the clearance of citalopram by inhibition of CYP2C19
p146
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006118
p147
sg23
Nsg24
Nsg25
Nsg26
Vcitalopram
p148
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/188
p149
sg34
Nsg35
Nsg36
Nsg37
Vmodafinil
p150
sa(dp151
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00745
p152
sg5
Vhttp://bio2rdf.org/drugbank:DB01104
p153
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vmodafinil is predicted to reduce the clearance of sertraline by inhibition of CYP2C19
p154
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006118
p155
sg23
Nsg24
Nsg25
Nsg26
Vsertraline
p156
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/189
p157
sg34
Nsg35
Nsg36
Nsg37
Vmodafinil
p158
sa(dp159
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00440
p160
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p161
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtrimethoprim is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C8
p162
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006119
p163
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p164
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/351
p165
sg34
Nsg35
Nsg36
Nsg37
Vtrimethoprim
p166
sa(dp167
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p168
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p169
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
p170
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p171
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p172
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/224
p173
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p174
sa(dp175
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p176
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p177
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p178
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p179
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p180
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/225
p181
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p182
sa(dp183
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p184
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p185
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p186
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p187
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p188
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/226
p189
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p190
sa(dp191
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p192
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p193
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p194
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p195
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p196
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/227
p197
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p198
sa(dp199
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p200
sg5
Vhttp://bio2rdf.org/drugbank:DB00715
p201
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
p202
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p203
sg23
Nsg24
Nsg25
Nsg26
Vparoxetine
p204
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/228
p205
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p206
sa(dp207
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p208
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p209
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
p210
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p211
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p212
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/229
p213
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p214
sa(dp215
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p216
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p217
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p218
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p219
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p220
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/273
p221
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p222
sa(dp223
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p224
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p225
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p226
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p227
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p228
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/517
p229
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p230
sa(dp231
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p232
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p233
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p234
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p235
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p236
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/518
p237
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p238
sa(dp239
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p240
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p241
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p242
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p243
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p244
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/520
p245
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p246
sa(dp247
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p248
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p249
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p250
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p251
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p252
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/521
p253
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p254
sa(dp255
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p256
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p257
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p258
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p259
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p260
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/636
p261
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p262
sa(dp263
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00472
p264
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p265
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluoxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p266
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p267
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p268
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/637
p269
sg34
Nsg35
Nsg36
Nsg37
Vfluoxetine
p270
sa(dp271
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p272
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p273
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p274
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p275
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p276
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/1
p277
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p278
sa(dp279
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p280
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p281
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p282
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p283
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p284
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/2
p285
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p286
sa(dp287
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p288
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p289
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p290
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p291
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p292
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/3
p293
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p294
sa(dp295
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p296
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p297
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p298
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p299
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p300
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/69
p301
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p302
sa(dp303
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p304
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p305
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p306
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p307
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p308
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/70
p309
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p310
sa(dp311
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p312
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p313
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p314
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p315
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p316
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/71
p317
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p318
sa(dp319
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p320
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p321
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p322
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p323
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p324
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/72
p325
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p326
sa(dp327
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p328
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p329
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p330
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p331
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p332
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/73
p333
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p334
sa(dp335
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p336
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p337
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p338
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p339
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p340
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/332
p341
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p342
sa(dp343
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p344
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p345
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p346
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p347
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p348
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/333
p349
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p350
sa(dp351
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p352
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p353
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p354
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p355
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p356
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/334
p357
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p358
sa(dp359
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p360
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p361
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p362
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p363
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p364
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/335
p365
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p366
sa(dp367
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p368
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p369
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
p370
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006120
p371
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p372
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/336
p373
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p374
sa(dp375
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p376
sg5
Vhttp://bio2rdf.org/drugbank:DB01098
p377
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
p378
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006120
p379
sg23
Nsg24
Nsg25
Nsg26
Vrosuvastatin
p380
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/416
p381
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p382
sa(dp383
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p384
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p385
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p386
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p387
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p388
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/423
p389
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p390
sa(dp391
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p392
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p393
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p394
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p395
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p396
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/424
p397
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p398
sa(dp399
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p400
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p401
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p402
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p403
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p404
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/426
p405
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p406
sa(dp407
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p408
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p409
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p410
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p411
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p412
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/427
p413
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p414
sa(dp415
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p416
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p417
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p418
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p419
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p420
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/582
p421
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p422
sa(dp423
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p424
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p425
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p426
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p427
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p428
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/583
p429
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p430
sa(dp431
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p432
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p433
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p434
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p435
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p436
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/673
p437
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p438
sa(dp439
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00549
p440
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p441
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vzafirlukast is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p442
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p443
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p444
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/693
p445
sg34
Nsg35
Nsg36
Nsg37
Vzafirlukast
p446
sa(dp447
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01059
p448
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p449
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnorfloxacin is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
p450
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p451
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p452
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/178
p453
sg34
Nsg35
Nsg36
Nsg37
Vnorfloxacin
p454
sa(dp455
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01059
p456
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p457
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnorfloxacin is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
p458
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p459
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p460
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/179
p461
sg34
Nsg35
Nsg36
Nsg37
Vnorfloxacin
p462
sa(dp463
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01059
p464
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p465
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnorfloxacin is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
p466
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p467
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p468
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/619
p469
sg34
Nsg35
Nsg36
Nsg37
Vnorfloxacin
p470
sa(dp471
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p472
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p473
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p474
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p475
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p476
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/7
p477
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p478
sa(dp479
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p480
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p481
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p482
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p483
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p484
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/8
p485
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p486
sa(dp487
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p488
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p489
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p490
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p491
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p492
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/9
p493
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p494
sa(dp495
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p496
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p497
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p498
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p499
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p500
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/44
p501
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p502
sa(dp503
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p504
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p505
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p506
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p507
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p508
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/45
p509
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p510
sa(dp511
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p512
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p513
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p514
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p515
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p516
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/46
p517
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p518
sa(dp519
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p520
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p521
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p522
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p523
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p524
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/83
p525
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p526
sa(dp527
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p528
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p529
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p530
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p531
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p532
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/84
p533
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p534
sa(dp535
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p536
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p537
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p538
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p539
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p540
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/85
p541
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p542
sa(dp543
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p544
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p545
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p546
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p547
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p548
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/86
p549
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p550
sa(dp551
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p552
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p553
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p554
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p555
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p556
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/87
p557
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p558
sa(dp559
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p560
sg5
Vhttp://bio2rdf.org/drugbank:DB00215
p561
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of citalopram by inhibition of CYP2C19
p562
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006118
p563
sg23
Nsg24
Nsg25
Nsg26
Vcitalopram
p564
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/88
p565
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p566
sa(dp567
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p568
sg5
Vhttp://bio2rdf.org/drugbank:DB01104
p569
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of sertraline by inhibition of CYP2C19
p570
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006118
p571
sg23
Nsg24
Nsg25
Nsg26
Vsertraline
p572
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/89
p573
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p574
sa(dp575
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p576
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p577
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p578
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p579
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p580
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/238
p581
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p582
sa(dp583
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p584
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p585
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p586
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p587
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p588
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/239
p589
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p590
sa(dp591
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p592
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p593
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p594
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p595
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p596
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/240
p597
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p598
sa(dp599
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p600
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p601
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p602
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p603
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p604
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/241
p605
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p606
sa(dp607
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p608
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p609
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p610
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p611
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p612
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/242
p613
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p614
sa(dp615
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p616
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p617
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p618
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p619
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p620
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/342
p621
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p622
sa(dp623
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p624
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p625
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p626
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p627
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p628
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/343
p629
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p630
sa(dp631
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p632
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p633
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p634
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p635
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p636
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/344
p637
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p638
sa(dp639
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p640
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p641
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p642
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p643
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p644
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/345
p645
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p646
sa(dp647
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p648
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p649
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
p650
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006120
p651
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p652
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/346
p653
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p654
sa(dp655
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p656
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p657
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p658
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p659
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p660
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/388
p661
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p662
sa(dp663
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p664
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p665
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p666
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p667
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p668
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/389
p669
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p670
sa(dp671
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p672
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p673
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p674
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p675
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p676
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/390
p677
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p678
sa(dp679
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p680
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p681
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p682
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p683
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p684
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/391
p685
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p686
sa(dp687
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p688
sg5
Vhttp://bio2rdf.org/drugbank:DB01098
p689
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
p690
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006120
p691
sg23
Nsg24
Nsg25
Nsg26
Vrosuvastatin
p692
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/418
p693
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p694
sa(dp695
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p696
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p697
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p698
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p699
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p700
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/433
p701
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p702
sa(dp703
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p704
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p705
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p706
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p707
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p708
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/434
p709
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p710
sa(dp711
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p712
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p713
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p714
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p715
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p716
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/436
p717
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p718
sa(dp719
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p720
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p721
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p722
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p723
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p724
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/437
p725
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p726
sa(dp727
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p728
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p729
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p730
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p731
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p732
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/527
p733
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p734
sa(dp735
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p736
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p737
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p738
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p739
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p740
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/528
p741
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p742
sa(dp743
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p744
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p745
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p746
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p747
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p748
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/530
p749
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p750
sa(dp751
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p752
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p753
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p754
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p755
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p756
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/531
p757
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p758
sa(dp759
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p760
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p761
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p762
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p763
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p764
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/588
p765
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p766
sa(dp767
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p768
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p769
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p770
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p771
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p772
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/589
p773
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p774
sa(dp775
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p776
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p777
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p778
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p779
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p780
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/641
p781
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p782
sa(dp783
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p784
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p785
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p786
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p787
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p788
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/642
p789
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p790
sa(dp791
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p792
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p793
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p794
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p795
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p796
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/675
p797
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p798
sa(dp799
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p800
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p801
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p802
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p803
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p804
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/692
p805
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p806
sa(dp807
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00582
p808
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p809
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvoriconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p810
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p811
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p812
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/695
p813
sg34
Nsg35
Nsg36
Nsg37
Vvoriconazole
p814
sa(dp815
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00199
p816
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p817
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Verythromycin is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p818
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p819
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p820
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/705
p821
sg34
Nsg35
Nsg36
Nsg37
Verythromycin
p822
sa(dp823
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p824
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p825
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p826
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p827
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p828
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/33
p829
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p830
sa(dp831
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p832
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p833
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p834
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p835
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p836
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/34
p837
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p838
sa(dp839
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p840
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p841
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p842
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p843
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p844
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/35
p845
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p846
sa(dp847
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00338
p848
sg5
Vhttp://bio2rdf.org/drugbank:DB00215
p849
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vomeprazole is predicted to reduce the clearance of citalopram by inhibition of CYP2C19
p850
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006118
p851
sg23
Nsg24
Nsg25
Nsg26
Vcitalopram
p852
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/176
p853
sg34
Nsg35
Nsg36
Nsg37
Vomeprazole
p854
sa(dp855
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00338
p856
sg5
Vhttp://bio2rdf.org/drugbank:DB01104
p857
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vomeprazole is predicted to reduce the clearance of sertraline by inhibition of CYP2C19
p858
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006118
p859
sg23
Nsg24
Nsg25
Nsg26
Vsertraline
p860
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/177
p861
sg34
Nsg35
Nsg36
Nsg37
Vomeprazole
p862
sa(dp863
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p864
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p865
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p866
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p867
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p868
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/199
p869
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p870
sa(dp871
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p872
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p873
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p874
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p875
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p876
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/200
p877
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p878
sa(dp879
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p880
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p881
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p882
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p883
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p884
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/201
p885
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p886
sa(dp887
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p888
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p889
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p890
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p891
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p892
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/202
p893
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p894
sa(dp895
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p896
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p897
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p898
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p899
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p900
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/203
p901
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p902
sa(dp903
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p904
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p905
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p906
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p907
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p908
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/373
p909
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p910
sa(dp911
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p912
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p913
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p914
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p915
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p916
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/374
p917
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p918
sa(dp919
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p920
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p921
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p922
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p923
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p924
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/376
p925
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p926
sa(dp927
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p928
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p929
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p930
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p931
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p932
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/503
p933
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p934
sa(dp935
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p936
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p937
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p938
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p939
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p940
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/504
p941
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p942
sa(dp943
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p944
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p945
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p946
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p947
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p948
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/506
p949
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p950
sa(dp951
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p952
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p953
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p954
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p955
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p956
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/507
p957
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p958
sa(dp959
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p960
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p961
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p962
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p963
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p964
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/627
p965
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p966
sa(dp967
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p968
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p969
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p970
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p971
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p972
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/687
p973
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p974
sa(dp975
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p976
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p977
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p978
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p979
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p980
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/702
p981
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p982
sa(dp983
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p984
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p985
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p986
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p987
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p988
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/47
p989
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p990
sa(dp991
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p992
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p993
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p994
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p995
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p996
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/48
p997
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p998
sa(dp999
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1000
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p1001
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p1002
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1003
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p1004
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/49
p1005
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1006
sa(dp1007
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1008
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p1009
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p1010
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1011
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p1012
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/251
p1013
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1014
sa(dp1015
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1016
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p1017
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p1018
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1019
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p1020
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/252
p1021
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1022
sa(dp1023
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1024
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p1025
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p1026
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1027
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p1028
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/253
p1029
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1030
sa(dp1031
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1032
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p1033
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p1034
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1035
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p1036
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/254
p1037
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1038
sa(dp1039
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1040
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p1041
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p1042
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1043
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p1044
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/255
p1045
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1046
sa(dp1047
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p1048
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p1049
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p1050
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1051
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p1052
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/375
p1053
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p1054
sa(dp1055
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1056
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p1057
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p1058
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1059
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p1060
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/392
p1061
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1062
sa(dp1063
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1064
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p1065
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p1066
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1067
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p1068
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/393
p1069
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1070
sa(dp1071
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1072
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p1073
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p1074
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1075
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p1076
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/394
p1077
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1078
sa(dp1079
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1080
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p1081
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p1082
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1083
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p1084
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/395
p1085
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1086
sa(dp1087
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1088
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p1089
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p1090
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1091
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p1092
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/537
p1093
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1094
sa(dp1095
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1096
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p1097
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p1098
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1099
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p1100
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/538
p1101
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1102
sa(dp1103
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1104
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p1105
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p1106
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1107
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p1108
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/540
p1109
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1110
sa(dp1111
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1112
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p1113
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p1114
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1115
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p1116
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/541
p1117
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1118
sa(dp1119
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01167
p1120
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p1121
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vitraconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p1122
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1123
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p1124
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/628
p1125
sg34
Nsg35
Nsg36
Nsg37
Vitraconazole
p1126
sa(dp1127
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1128
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p1129
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p1130
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1131
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p1132
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/646
p1133
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1134
sa(dp1135
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1136
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p1137
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p1138
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1139
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p1140
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/647
p1141
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1142
sa(dp1143
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1144
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p1145
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p1146
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1147
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p1148
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/706
p1149
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1150
sa(dp1151
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00343
p1152
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p1153
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vdiltiazem is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p1154
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1155
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p1156
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/707
p1157
sg34
Nsg35
Nsg36
Nsg37
Vdiltiazem
p1158
sa(dp1159
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1160
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p1161
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
p1162
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1163
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p1164
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/107
p1165
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1166
sa(dp1167
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1168
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p1169
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p1170
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1171
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p1172
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/108
p1173
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1174
sa(dp1175
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1176
sg5
Vhttp://bio2rdf.org/drugbank:DB00472
p1177
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
p1178
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1179
sg23
Nsg24
Nsg25
Nsg26
Vfluoxetine
p1180
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/109
p1181
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1182
sa(dp1183
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1184
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p1185
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p1186
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1187
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p1188
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/110
p1189
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1190
sa(dp1191
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1192
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p1193
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p1194
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1195
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p1196
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/111
p1197
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1198
sa(dp1199
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1200
sg5
Vhttp://bio2rdf.org/drugbank:DB00715
p1201
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
p1202
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1203
sg23
Nsg24
Nsg25
Nsg26
Vparoxetine
p1204
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/112
p1205
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1206
sa(dp1207
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1208
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p1209
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
p1210
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1211
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p1212
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/113
p1213
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1214
sa(dp1215
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1216
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p1217
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p1218
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1219
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p1220
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/266
p1221
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1222
sa(dp1223
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1224
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p1225
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p1226
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1227
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p1228
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/448
p1229
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1230
sa(dp1231
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1232
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p1233
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p1234
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1235
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p1236
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/449
p1237
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1238
sa(dp1239
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1240
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p1241
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p1242
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1243
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p1244
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/451
p1245
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1246
sa(dp1247
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1248
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p1249
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p1250
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1251
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p1252
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/452
p1253
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1254
sa(dp1255
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1256
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p1257
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p1258
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1259
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p1260
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/597
p1261
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1262
sa(dp1263
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00857
p1264
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p1265
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vterbinafine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p1266
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1267
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p1268
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/598
p1269
sg34
Nsg35
Nsg36
Nsg37
Vterbinafine
p1270
sa(dp1271
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1272
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p1273
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
p1274
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1275
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p1276
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/100
p1277
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1278
sa(dp1279
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1280
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p1281
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p1282
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1283
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p1284
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/101
p1285
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1286
sa(dp1287
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1288
sg5
Vhttp://bio2rdf.org/drugbank:DB00472
p1289
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
p1290
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1291
sg23
Nsg24
Nsg25
Nsg26
Vfluoxetine
p1292
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/102
p1293
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1294
sa(dp1295
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1296
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p1297
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p1298
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1299
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p1300
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/103
p1301
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1302
sa(dp1303
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1304
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p1305
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p1306
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1307
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p1308
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/104
p1309
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1310
sa(dp1311
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1312
sg5
Vhttp://bio2rdf.org/drugbank:DB00715
p1313
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
p1314
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1315
sg23
Nsg24
Nsg25
Nsg26
Vparoxetine
p1316
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/105
p1317
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1318
sa(dp1319
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1320
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p1321
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p1322
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1323
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p1324
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/265
p1325
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1326
sa(dp1327
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1328
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p1329
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p1330
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1331
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p1332
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/443
p1333
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1334
sa(dp1335
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1336
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p1337
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p1338
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1339
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p1340
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/444
p1341
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1342
sa(dp1343
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1344
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p1345
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p1346
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1347
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p1348
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/446
p1349
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1350
sa(dp1351
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1352
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p1353
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p1354
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1355
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p1356
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/447
p1357
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1358
sa(dp1359
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1360
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p1361
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p1362
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1363
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p1364
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/595
p1365
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1366
sa(dp1367
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00285
p1368
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p1369
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vvenlafaxine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p1370
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1371
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p1372
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/596
p1373
sg34
Nsg35
Nsg36
Nsg37
Vvenlafaxine
p1374
sa(dp1375
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1376
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p1377
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p1378
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1379
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p1380
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/16
p1381
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1382
sa(dp1383
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1384
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p1385
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p1386
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1387
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p1388
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/116
p1389
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1390
sa(dp1391
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1392
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p1393
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p1394
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1395
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p1396
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/454
p1397
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1398
sa(dp1399
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1400
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p1401
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
p1402
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p1403
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p1404
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/678
p1405
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1406
sa(dp1407
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1408
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p1409
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p1410
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1411
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p1412
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/679
p1413
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1414
sa(dp1415
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1416
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p1417
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p1418
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1419
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p1420
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/697
p1421
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1422
sa(dp1423
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1424
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p1425
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
p1426
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p1427
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p1428
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/14
p1429
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1430
sa(dp1431
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1432
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p1433
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p1434
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1435
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p1436
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/15
p1437
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1438
sa(dp1439
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1440
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p1441
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p1442
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1443
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p1444
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/17
p1445
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1446
sa(dp1447
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1448
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p1449
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
p1450
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p1451
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p1452
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/114
p1453
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1454
sa(dp1455
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1456
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p1457
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p1458
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1459
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p1460
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/117
p1461
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1462
sa(dp1463
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1464
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p1465
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p1466
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1467
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p1468
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/118
p1469
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1470
sa(dp1471
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1472
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p1473
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p1474
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1475
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p1476
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/119
p1477
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1478
sa(dp1479
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1480
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p1481
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p1482
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1483
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p1484
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/120
p1485
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1486
sa(dp1487
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1488
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p1489
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p1490
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1491
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p1492
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/244
p1493
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1494
sa(dp1495
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1496
sg5
Vhttp://bio2rdf.org/drugbank:DB00472
p1497
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
p1498
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1499
sg23
Nsg24
Nsg25
Nsg26
Vfluoxetine
p1500
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/245
p1501
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1502
sa(dp1503
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1504
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p1505
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p1506
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1507
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p1508
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/353
p1509
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1510
sa(dp1511
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1512
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p1513
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p1514
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1515
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p1516
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/354
p1517
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1518
sa(dp1519
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1520
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p1521
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p1522
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1523
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p1524
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/355
p1525
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1526
sa(dp1527
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1528
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p1529
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p1530
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1531
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p1532
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/356
p1533
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1534
sa(dp1535
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1536
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p1537
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p1538
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1539
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p1540
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/453
p1541
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1542
sa(dp1543
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1544
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p1545
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p1546
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1547
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p1548
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/456
p1549
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1550
sa(dp1551
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1552
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p1553
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p1554
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1555
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p1556
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/457
p1557
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1558
sa(dp1559
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1560
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p1561
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p1562
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1563
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p1564
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/599
p1565
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1566
sa(dp1567
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00976
p1568
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p1569
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vtelithromycin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p1570
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1571
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p1572
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/600
p1573
sg34
Nsg35
Nsg36
Nsg37
Vtelithromycin
p1574
sa(dp1575
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1576
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p1577
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
p1578
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p1579
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p1580
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/61
p1581
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1582
sa(dp1583
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1584
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p1585
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p1586
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1587
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p1588
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/62
p1589
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1590
sa(dp1591
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1592
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p1593
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p1594
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1595
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p1596
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/63
p1597
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1598
sa(dp1599
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1600
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p1601
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p1602
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1603
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p1604
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/64
p1605
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1606
sa(dp1607
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1608
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p1609
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p1610
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1611
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p1612
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/161
p1613
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1614
sa(dp1615
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1616
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p1617
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p1618
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1619
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p1620
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/246
p1621
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1622
sa(dp1623
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1624
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p1625
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p1626
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1627
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p1628
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/247
p1629
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1630
sa(dp1631
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1632
sg5
Vhttp://bio2rdf.org/drugbank:DB00715
p1633
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
p1634
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1635
sg23
Nsg24
Nsg25
Nsg26
Vparoxetine
p1636
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/248
p1637
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1638
sa(dp1639
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1640
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p1641
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
p1642
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1643
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p1644
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/249
p1645
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1646
sa(dp1647
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1648
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p1649
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p1650
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1651
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p1652
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/274
p1653
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1654
sa(dp1655
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1656
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p1657
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
p1658
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p1659
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p1660
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/308
p1661
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1662
sa(dp1663
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1664
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p1665
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p1666
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1667
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p1668
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/310
p1669
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1670
sa(dp1671
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1672
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p1673
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p1674
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1675
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p1676
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/311
p1677
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1678
sa(dp1679
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1680
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p1681
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p1682
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1683
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p1684
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/312
p1685
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1686
sa(dp1687
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1688
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p1689
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p1690
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1691
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p1692
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/313
p1693
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1694
sa(dp1695
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1696
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p1697
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p1698
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1699
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p1700
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/314
p1701
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1702
sa(dp1703
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1704
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p1705
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p1706
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1707
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p1708
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/407
p1709
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1710
sa(dp1711
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1712
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p1713
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p1714
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1715
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p1716
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/408
p1717
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1718
sa(dp1719
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1720
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p1721
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p1722
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1723
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p1724
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/409
p1725
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1726
sa(dp1727
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1728
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p1729
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p1730
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1731
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p1732
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/410
p1733
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1734
sa(dp1735
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1736
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p1737
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p1738
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1739
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p1740
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/532
p1741
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1742
sa(dp1743
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1744
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p1745
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p1746
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1747
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p1748
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/533
p1749
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1750
sa(dp1751
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1752
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p1753
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p1754
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1755
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p1756
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/535
p1757
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1758
sa(dp1759
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1760
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p1761
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p1762
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1763
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p1764
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/536
p1765
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1766
sa(dp1767
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1768
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p1769
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p1770
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1771
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p1772
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/567
p1773
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1774
sa(dp1775
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1776
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p1777
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p1778
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1779
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p1780
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/568
p1781
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1782
sa(dp1783
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1784
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p1785
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p1786
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1787
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p1788
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/570
p1789
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1790
sa(dp1791
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1792
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p1793
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p1794
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1795
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p1796
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/571
p1797
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1798
sa(dp1799
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1800
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p1801
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p1802
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1803
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p1804
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/644
p1805
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1806
sa(dp1807
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00476
p1808
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p1809
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vduloxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p1810
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1811
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p1812
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/645
p1813
sg34
Nsg35
Nsg36
Nsg37
Vduloxetine
p1814
sa(dp1815
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1816
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p1817
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p1818
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1819
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p1820
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/664
p1821
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1822
sa(dp1823
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1824
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p1825
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p1826
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1827
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p1828
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/665
p1829
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1830
sa(dp1831
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1832
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p1833
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
p1834
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p1835
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p1836
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/716
p1837
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1838
sa(dp1839
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1840
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p1841
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p1842
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1843
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p1844
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/717
p1845
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1846
sa(dp1847
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01072
p1848
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p1849
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatazanavir is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p1850
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1851
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p1852
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/718
p1853
sg34
Nsg35
Nsg36
Nsg37
Vatazanavir
p1854
sa(dp1855
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1856
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p1857
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
p1858
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1859
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p1860
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/160
p1861
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1862
sa(dp1863
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1864
sg5
Vhttp://bio2rdf.org/drugbank:DB00472
p1865
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
p1866
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1867
sg23
Nsg24
Nsg25
Nsg26
Vfluoxetine
p1868
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/162
p1869
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1870
sa(dp1871
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1872
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p1873
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p1874
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1875
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p1876
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/163
p1877
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1878
sa(dp1879
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1880
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p1881
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p1882
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1883
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p1884
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/164
p1885
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1886
sa(dp1887
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1888
sg5
Vhttp://bio2rdf.org/drugbank:DB00715
p1889
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
p1890
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1891
sg23
Nsg24
Nsg25
Nsg26
Vparoxetine
p1892
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/165
p1893
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1894
sa(dp1895
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1896
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p1897
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
p1898
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1899
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p1900
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/166
p1901
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1902
sa(dp1903
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1904
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p1905
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p1906
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1907
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p1908
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/270
p1909
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1910
sa(dp1911
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1912
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p1913
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p1914
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1915
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p1916
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/483
p1917
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1918
sa(dp1919
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1920
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p1921
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p1922
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1923
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p1924
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/484
p1925
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1926
sa(dp1927
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1928
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p1929
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p1930
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1931
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p1932
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/486
p1933
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1934
sa(dp1935
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1936
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p1937
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p1938
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1939
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p1940
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/487
p1941
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1942
sa(dp1943
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1944
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p1945
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p1946
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1947
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p1948
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/614
p1949
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1950
sa(dp1951
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00908
p1952
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p1953
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vquinidine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p1954
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p1955
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p1956
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/615
p1957
sg34
Nsg35
Nsg36
Nsg37
Vquinidine
p1958
sa(dp1959
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p1960
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p1961
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p1962
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1963
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p1964
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/58
p1965
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p1966
sa(dp1967
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p1968
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p1969
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p1970
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1971
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p1972
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/59
p1973
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p1974
sa(dp1975
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p1976
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p1977
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p1978
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p1979
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p1980
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/60
p1981
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p1982
sa(dp1983
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00176
p1984
sg5
Vhttp://bio2rdf.org/drugbank:DB00215
p1985
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluvoxamine is predicted to reduce the clearance of citalopram by inhibition of CYP2C19
p1986
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006118
p1987
sg23
Nsg24
Nsg25
Nsg26
Vcitalopram
p1988
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/219
p1989
sg34
Nsg35
Nsg36
Nsg37
Vfluvoxamine
p1990
sa(dp1991
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00176
p1992
sg5
Vhttp://bio2rdf.org/drugbank:DB01104
p1993
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluvoxamine is predicted to reduce the clearance of sertraline by inhibition of CYP2C19
p1994
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006118
p1995
sg23
Nsg24
Nsg25
Nsg26
Vsertraline
p1996
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/220
p1997
sg34
Nsg35
Nsg36
Nsg37
Vfluvoxamine
p1998
sa(dp1999
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00176
p2000
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p2001
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluvoxamine is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
p2002
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p2003
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p2004
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/221
p2005
sg34
Nsg35
Nsg36
Nsg37
Vfluvoxamine
p2006
sa(dp2007
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00176
p2008
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p2009
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluvoxamine is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
p2010
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p2011
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p2012
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/222
p2013
sg34
Nsg35
Nsg36
Nsg37
Vfluvoxamine
p2014
sa(dp2015
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00537
p2016
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p2017
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vciprofloxacin is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
p2018
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p2019
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p2020
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/263
p2021
sg34
Nsg35
Nsg36
Nsg37
Vciprofloxacin
p2022
sa(dp2023
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00537
p2024
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p2025
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vciprofloxacin is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
p2026
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p2027
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p2028
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/264
p2029
sg34
Nsg35
Nsg36
Nsg37
Vciprofloxacin
p2030
sa(dp2031
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2032
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p2033
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p2034
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2035
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p2036
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/303
p2037
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2038
sa(dp2039
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2040
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p2041
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p2042
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2043
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p2044
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/304
p2045
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2046
sa(dp2047
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2048
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p2049
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p2050
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2051
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p2052
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/305
p2053
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2054
sa(dp2055
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2056
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p2057
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p2058
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2059
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p2060
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/306
p2061
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2062
sa(dp2063
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2064
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p2065
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p2066
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2067
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p2068
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/307
p2069
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2070
sa(dp2071
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00176
p2072
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p2073
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluvoxamine is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
p2074
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006120
p2075
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p2076
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/382
p2077
sg34
Nsg35
Nsg36
Nsg37
Vfluvoxamine
p2078
sa(dp2079
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2080
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p2081
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p2082
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2083
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p2084
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/404
p2085
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2086
sa(dp2087
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2088
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p2089
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p2090
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2091
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p2092
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/405
p2093
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2094
sa(dp2095
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2096
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p2097
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p2098
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2099
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p2100
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/406
p2101
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2102
sa(dp2103
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00176
p2104
sg5
Vhttp://bio2rdf.org/drugbank:DB01098
p2105
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluvoxamine is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
p2106
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006120
p2107
sg23
Nsg24
Nsg25
Nsg26
Vrosuvastatin
p2108
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/420
p2109
sg34
Nsg35
Nsg36
Nsg37
Vfluvoxamine
p2110
sa(dp2111
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2112
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p2113
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p2114
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2115
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p2116
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/562
p2117
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2118
sa(dp2119
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2120
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p2121
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p2122
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2123
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p2124
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/563
p2125
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2126
sa(dp2127
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2128
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p2129
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p2130
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2131
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p2132
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/565
p2133
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2134
sa(dp2135
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2136
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p2137
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p2138
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2139
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p2140
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/566
p2141
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2142
sa(dp2143
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00176
p2144
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p2145
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluvoxamine is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
p2146
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p2147
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p2148
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/635
p2149
sg34
Nsg35
Nsg36
Nsg37
Vfluvoxamine
p2150
sa(dp2151
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00537
p2152
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p2153
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vciprofloxacin is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
p2154
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p2155
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p2156
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/652
p2157
sg34
Nsg35
Nsg36
Nsg37
Vciprofloxacin
p2158
sa(dp2159
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2160
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p2161
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p2162
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2163
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p2164
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/661
p2165
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2166
sa(dp2167
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2168
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p2169
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p2170
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2171
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p2172
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/662
p2173
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2174
sa(dp2175
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2176
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p2177
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p2178
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2179
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p2180
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/714
p2181
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2182
sa(dp2183
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01076
p2184
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p2185
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vatorvastatin is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p2186
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2187
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p2188
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/715
p2189
sg34
Nsg35
Nsg36
Nsg37
Vatorvastatin
p2190
sa(dp2191
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2192
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p2193
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p2194
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2195
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p2196
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/31
p2197
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2198
sa(dp2199
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2200
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p2201
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p2202
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2203
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p2204
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/193
p2205
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2206
sa(dp2207
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2208
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p2209
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p2210
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2211
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p2212
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/499
p2213
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2214
sa(dp2215
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2216
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p2217
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p2218
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2219
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p2220
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/686
p2221
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2222
sa(dp2223
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2224
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p2225
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p2226
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2227
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p2228
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/701
p2229
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2230
sa(dp2231
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2232
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p2233
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p2234
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2235
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p2236
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/30
p2237
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2238
sa(dp2239
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2240
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p2241
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p2242
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2243
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p2244
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/32
p2245
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2246
sa(dp2247
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00379
p2248
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p2249
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vmexiletine is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
p2250
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p2251
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p2252
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/190
p2253
sg34
Nsg35
Nsg36
Nsg37
Vmexiletine
p2254
sa(dp2255
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00379
p2256
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p2257
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vmexiletine is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
p2258
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p2259
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p2260
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/191
p2261
sg34
Nsg35
Nsg36
Nsg37
Vmexiletine
p2262
sa(dp2263
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2264
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p2265
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p2266
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2267
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p2268
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/194
p2269
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2270
sa(dp2271
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2272
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p2273
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p2274
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2275
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p2276
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/195
p2277
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2278
sa(dp2279
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2280
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p2281
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p2282
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2283
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p2284
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/196
p2285
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2286
sa(dp2287
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2288
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p2289
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p2290
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2291
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p2292
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/197
p2293
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2294
sa(dp2295
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2296
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p2297
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p2298
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2299
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p2300
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/369
p2301
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2302
sa(dp2303
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2304
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p2305
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p2306
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2307
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p2308
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/370
p2309
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2310
sa(dp2311
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2312
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p2313
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p2314
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2315
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p2316
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/371
p2317
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2318
sa(dp2319
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2320
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p2321
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p2322
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2323
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p2324
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/372
p2325
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2326
sa(dp2327
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01241
p2328
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p2329
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vgemfibrozil is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C8
p2330
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006119
p2331
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p2332
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/381
p2333
sg34
Nsg35
Nsg36
Nsg37
Vgemfibrozil
p2334
sa(dp2335
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2336
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p2337
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p2338
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2339
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p2340
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/498
p2341
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2342
sa(dp2343
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2344
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p2345
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p2346
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2347
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p2348
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/501
p2349
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2350
sa(dp2351
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2352
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p2353
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p2354
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2355
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p2356
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/502
p2357
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2358
sa(dp2359
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00379
p2360
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p2361
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vmexiletine is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
p2362
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p2363
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p2364
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/623
p2365
sg34
Nsg35
Nsg36
Nsg37
Vmexiletine
p2366
sa(dp2367
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2368
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p2369
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p2370
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2371
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p2372
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/624
p2373
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2374
sa(dp2375
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01026
p2376
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p2377
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vketoconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p2378
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2379
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p2380
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/625
p2381
sg34
Nsg35
Nsg36
Nsg37
Vketoconazole
p2382
sa(dp2383
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2384
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p2385
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
p2386
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p2387
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p2388
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/36
p2389
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2390
sa(dp2391
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2392
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p2393
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p2394
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2395
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p2396
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/37
p2397
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2398
sa(dp2399
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2400
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p2401
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p2402
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2403
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p2404
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/38
p2405
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2406
sa(dp2407
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2408
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p2409
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p2410
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2411
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p2412
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/39
p2413
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2414
sa(dp2415
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2416
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p2417
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
p2418
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p2419
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p2420
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/204
p2421
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2422
sa(dp2423
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2424
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p2425
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p2426
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2427
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p2428
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/206
p2429
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2430
sa(dp2431
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2432
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p2433
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p2434
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2435
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p2436
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/207
p2437
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2438
sa(dp2439
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2440
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p2441
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p2442
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2443
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p2444
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/208
p2445
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2446
sa(dp2447
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2448
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p2449
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p2450
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2451
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p2452
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/209
p2453
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2454
sa(dp2455
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2456
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p2457
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p2458
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2459
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p2460
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/210
p2461
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2462
sa(dp2463
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2464
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p2465
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p2466
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2467
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p2468
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/377
p2469
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2470
sa(dp2471
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2472
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p2473
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p2474
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2475
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p2476
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/378
p2477
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2478
sa(dp2479
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2480
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p2481
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p2482
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2483
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p2484
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/379
p2485
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2486
sa(dp2487
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2488
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p2489
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p2490
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2491
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p2492
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/380
p2493
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2494
sa(dp2495
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2496
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p2497
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p2498
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2499
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p2500
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/508
p2501
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2502
sa(dp2503
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2504
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p2505
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p2506
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2507
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p2508
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/509
p2509
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2510
sa(dp2511
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2512
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p2513
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p2514
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2515
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p2516
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/511
p2517
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2518
sa(dp2519
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2520
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p2521
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p2522
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2523
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p2524
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/512
p2525
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2526
sa(dp2527
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2528
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p2529
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p2530
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2531
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p2532
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/630
p2533
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2534
sa(dp2535
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2536
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p2537
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p2538
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2539
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p2540
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/631
p2541
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2542
sa(dp2543
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2544
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p2545
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
p2546
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p2547
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p2548
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/688
p2549
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2550
sa(dp2551
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2552
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p2553
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p2554
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2555
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p2556
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/689
p2557
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2558
sa(dp2559
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00224
p2560
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p2561
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vindinavir is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p2562
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2563
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p2564
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/703
p2565
sg34
Nsg35
Nsg36
Nsg37
Vindinavir
p2566
sa(dp2567
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2568
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p2569
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
p2570
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p2571
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p2572
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/22
p2573
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2574
sa(dp2575
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2576
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p2577
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p2578
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2579
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p2580
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/23
p2581
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2582
sa(dp2583
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2584
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p2585
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p2586
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2587
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p2588
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/24
p2589
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2590
sa(dp2591
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2592
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p2593
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p2594
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2595
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p2596
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/25
p2597
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2598
sa(dp2599
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2600
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p2601
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
p2602
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p2603
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p2604
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/144
p2605
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2606
sa(dp2607
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2608
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p2609
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p2610
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2611
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p2612
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/146
p2613
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2614
sa(dp2615
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2616
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p2617
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p2618
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2619
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p2620
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/147
p2621
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2622
sa(dp2623
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2624
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p2625
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p2626
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2627
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p2628
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/148
p2629
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2630
sa(dp2631
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2632
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p2633
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p2634
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2635
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p2636
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/149
p2637
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2638
sa(dp2639
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2640
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p2641
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p2642
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2643
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p2644
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/150
p2645
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2646
sa(dp2647
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2648
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p2649
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
p2650
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2651
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p2652
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/152
p2653
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2654
sa(dp2655
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2656
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p2657
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p2658
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2659
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p2660
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/153
p2661
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2662
sa(dp2663
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2664
sg5
Vhttp://bio2rdf.org/drugbank:DB00472
p2665
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
p2666
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2667
sg23
Nsg24
Nsg25
Nsg26
Vfluoxetine
p2668
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/154
p2669
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2670
sa(dp2671
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2672
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p2673
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p2674
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2675
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p2676
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/155
p2677
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2678
sa(dp2679
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2680
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p2681
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p2682
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2683
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p2684
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/156
p2685
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2686
sa(dp2687
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2688
sg5
Vhttp://bio2rdf.org/drugbank:DB00715
p2689
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
p2690
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2691
sg23
Nsg24
Nsg25
Nsg26
Vparoxetine
p2692
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/157
p2693
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2694
sa(dp2695
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2696
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p2697
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
p2698
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2699
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p2700
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/158
p2701
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2702
sa(dp2703
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2704
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p2705
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p2706
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2707
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p2708
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/269
p2709
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2710
sa(dp2711
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2712
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p2713
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p2714
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2715
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p2716
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/361
p2717
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2718
sa(dp2719
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2720
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p2721
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p2722
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2723
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p2724
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/362
p2725
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2726
sa(dp2727
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2728
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p2729
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p2730
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2731
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p2732
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/363
p2733
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2734
sa(dp2735
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2736
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p2737
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p2738
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2739
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p2740
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/364
p2741
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2742
sa(dp2743
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2744
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p2745
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p2746
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2747
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p2748
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/473
p2749
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2750
sa(dp2751
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2752
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p2753
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p2754
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2755
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p2756
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/474
p2757
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2758
sa(dp2759
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2760
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p2761
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p2762
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2763
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p2764
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/476
p2765
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2766
sa(dp2767
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2768
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p2769
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p2770
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2771
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p2772
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/477
p2773
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2774
sa(dp2775
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2776
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p2777
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p2778
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2779
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p2780
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/478
p2781
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2782
sa(dp2783
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2784
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p2785
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p2786
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2787
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p2788
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/479
p2789
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2790
sa(dp2791
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2792
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p2793
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p2794
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2795
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p2796
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/481
p2797
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2798
sa(dp2799
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2800
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p2801
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p2802
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2803
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p2804
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/482
p2805
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2806
sa(dp2807
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2808
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p2809
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p2810
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2811
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p2812
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/609
p2813
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2814
sa(dp2815
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2816
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p2817
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p2818
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2819
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p2820
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/610
p2821
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2822
sa(dp2823
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2824
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p2825
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p2826
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2827
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p2828
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/612
p2829
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2830
sa(dp2831
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2832
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p2833
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p2834
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2835
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p2836
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/613
p2837
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2838
sa(dp2839
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2840
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p2841
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
p2842
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p2843
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p2844
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/682
p2845
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2846
sa(dp2847
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2848
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p2849
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p2850
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2851
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p2852
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/683
p2853
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2854
sa(dp2855
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00243
p2856
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p2857
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vranolazine is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p2858
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2859
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p2860
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/699
p2861
sg34
Nsg35
Nsg36
Nsg37
Vranolazine
p2862
sa(dp2863
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2864
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p2865
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p2866
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2867
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p2868
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/171
p2869
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2870
sa(dp2871
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2872
sg5
Vhttp://bio2rdf.org/drugbank:DB00472
p2873
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
p2874
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2875
sg23
Nsg24
Nsg25
Nsg26
Vfluoxetine
p2876
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/172
p2877
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2878
sa(dp2879
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2880
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p2881
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
p2882
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2883
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p2884
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/175
p2885
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2886
sa(dp2887
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2888
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p2889
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p2890
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2891
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p2892
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/489
p2893
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2894
sa(dp2895
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2896
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p2897
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p2898
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2899
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p2900
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/618
p2901
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2902
sa(dp2903
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p2904
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p2905
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p2906
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2907
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p2908
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/42
p2909
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p2910
sa(dp2911
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2912
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p2913
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
p2914
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2915
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p2916
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/170
p2917
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2918
sa(dp2919
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2920
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p2921
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p2922
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2923
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p2924
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/173
p2925
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2926
sa(dp2927
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2928
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p2929
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p2930
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2931
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p2932
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/174
p2933
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2934
sa(dp2935
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p2936
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p2937
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p2938
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p2939
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p2940
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/232
p2941
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p2942
sa(dp2943
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2944
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p2945
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p2946
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2947
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p2948
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/271
p2949
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2950
sa(dp2951
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p2952
sg5
Vhttp://bio2rdf.org/drugbank:DB01098
p2953
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
p2954
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006120
p2955
sg23
Nsg24
Nsg25
Nsg26
Vrosuvastatin
p2956
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/421
p2957
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p2958
sa(dp2959
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2960
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p2961
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p2962
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2963
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p2964
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/488
p2965
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2966
sa(dp2967
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2968
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p2969
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p2970
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2971
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p2972
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/491
p2973
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2974
sa(dp2975
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2976
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p2977
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p2978
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2979
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p2980
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/492
p2981
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2982
sa(dp2983
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00715
p2984
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p2985
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vparoxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p2986
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p2987
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p2988
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/617
p2989
sg34
Nsg35
Nsg36
Nsg37
Vparoxetine
p2990
sa(dp2991
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p2992
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p2993
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
p2994
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p2995
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p2996
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/690
p2997
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p2998
sa(dp2999
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3000
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p3001
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p3002
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3003
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p3004
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/691
p3005
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3006
sa(dp3007
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3008
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p3009
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
p3010
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3011
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p3012
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/40
p3013
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3014
sa(dp3015
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3016
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p3017
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p3018
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3019
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p3020
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/41
p3021
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3022
sa(dp3023
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3024
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p3025
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p3026
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3027
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p3028
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/43
p3029
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3030
sa(dp3031
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3032
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p3033
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
p3034
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3035
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p3036
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/54
p3037
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3038
sa(dp3039
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3040
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p3041
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p3042
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3043
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p3044
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/55
p3045
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3046
sa(dp3047
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3048
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p3049
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p3050
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3051
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p3052
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/56
p3053
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3054
sa(dp3055
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3056
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p3057
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p3058
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3059
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p3060
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/57
p3061
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3062
sa(dp3063
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3064
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p3065
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
p3066
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3067
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p3068
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/230
p3069
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3070
sa(dp3071
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3072
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p3073
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p3074
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3075
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p3076
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/233
p3077
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3078
sa(dp3079
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3080
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p3081
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p3082
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3083
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p3084
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/234
p3085
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3086
sa(dp3087
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3088
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p3089
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p3090
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3091
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p3092
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/235
p3093
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3094
sa(dp3095
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3096
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p3097
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p3098
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3099
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p3100
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/236
p3101
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3102
sa(dp3103
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3104
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p3105
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p3106
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3107
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p3108
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/277
p3109
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3110
sa(dp3111
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3112
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p3113
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
p3114
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3115
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p3116
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/284
p3117
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3118
sa(dp3119
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3120
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p3121
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p3122
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3123
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p3124
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/286
p3125
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3126
sa(dp3127
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3128
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p3129
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p3130
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3131
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p3132
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/287
p3133
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3134
sa(dp3135
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3136
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p3137
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p3138
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3139
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p3140
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/288
p3141
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3142
sa(dp3143
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3144
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p3145
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p3146
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3147
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p3148
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/289
p3149
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3150
sa(dp3151
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3152
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p3153
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p3154
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3155
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p3156
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/290
p3157
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3158
sa(dp3159
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3160
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p3161
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
p3162
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p3163
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p3164
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/291
p3165
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3166
sa(dp3167
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3168
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p3169
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
p3170
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p3171
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p3172
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/292
p3173
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3174
sa(dp3175
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3176
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p3177
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p3178
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3179
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p3180
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/383
p3181
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3182
sa(dp3183
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3184
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p3185
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p3186
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3187
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p3188
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/384
p3189
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3190
sa(dp3191
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3192
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p3193
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p3194
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3195
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p3196
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/385
p3197
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3198
sa(dp3199
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3200
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p3201
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p3202
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3203
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p3204
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/386
p3205
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3206
sa(dp3207
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3208
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p3209
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
p3210
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006120
p3211
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p3212
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/387
p3213
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3214
sa(dp3215
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3216
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p3217
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p3218
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3219
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p3220
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/400
p3221
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3222
sa(dp3223
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3224
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p3225
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p3226
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3227
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p3228
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/401
p3229
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3230
sa(dp3231
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3232
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p3233
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p3234
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3235
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p3236
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/402
p3237
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3238
sa(dp3239
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3240
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p3241
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p3242
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3243
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p3244
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/403
p3245
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3246
sa(dp3247
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3248
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p3249
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p3250
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3251
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p3252
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/522
p3253
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3254
sa(dp3255
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3256
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p3257
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p3258
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3259
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p3260
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/523
p3261
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3262
sa(dp3263
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3264
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p3265
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p3266
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3267
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p3268
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/525
p3269
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3270
sa(dp3271
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3272
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p3273
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p3274
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3275
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p3276
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/526
p3277
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3278
sa(dp3279
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3280
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p3281
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p3282
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3283
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p3284
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/552
p3285
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3286
sa(dp3287
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3288
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p3289
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p3290
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3291
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p3292
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/553
p3293
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3294
sa(dp3295
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3296
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p3297
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p3298
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3299
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p3300
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/555
p3301
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3302
sa(dp3303
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3304
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p3305
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p3306
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3307
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p3308
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/556
p3309
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3310
sa(dp3311
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3312
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p3313
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p3314
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3315
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p3316
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/638
p3317
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3318
sa(dp3319
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3320
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p3321
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p3322
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3323
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p3324
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/639
p3325
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3326
sa(dp3327
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3328
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p3329
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p3330
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3331
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p3332
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/655
p3333
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3334
sa(dp3335
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3336
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p3337
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p3338
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3339
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p3340
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/656
p3341
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3342
sa(dp3343
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3344
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p3345
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
p3346
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p3347
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p3348
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/658
p3349
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3350
sa(dp3351
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00196
p3352
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p3353
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vfluconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p3354
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3355
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p3356
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/704
p3357
sg34
Nsg35
Nsg36
Nsg37
Vfluconazole
p3358
sa(dp3359
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3360
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p3361
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
p3362
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3363
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p3364
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/711
p3365
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3366
sa(dp3367
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3368
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p3369
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p3370
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3371
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p3372
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/712
p3373
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3374
sa(dp3375
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00501
p3376
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p3377
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcimetidine is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p3378
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3379
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p3380
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/713
p3381
sg34
Nsg35
Nsg36
Nsg37
Vcimetidine
p3382
sa(dp3383
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3384
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p3385
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
p3386
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3387
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p3388
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/26
p3389
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3390
sa(dp3391
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3392
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p3393
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p3394
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3395
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p3396
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/27
p3397
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3398
sa(dp3399
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3400
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p3401
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p3402
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3403
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p3404
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/28
p3405
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3406
sa(dp3407
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3408
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p3409
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p3410
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3411
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p3412
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/29
p3413
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3414
sa(dp3415
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3416
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p3417
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
p3418
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3419
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p3420
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/180
p3421
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3422
sa(dp3423
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3424
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p3425
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p3426
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3427
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p3428
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/182
p3429
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3430
sa(dp3431
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3432
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p3433
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p3434
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3435
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p3436
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/183
p3437
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3438
sa(dp3439
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3440
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p3441
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p3442
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3443
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p3444
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/184
p3445
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3446
sa(dp3447
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3448
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p3449
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p3450
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3451
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p3452
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/185
p3453
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3454
sa(dp3455
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3456
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p3457
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
p3458
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3459
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p3460
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/276
p3461
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3462
sa(dp3463
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3464
sg5
Vhttp://bio2rdf.org/drugbank:DB00472
p3465
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
p3466
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3467
sg23
Nsg24
Nsg25
Nsg26
Vfluoxetine
p3468
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/278
p3469
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3470
sa(dp3471
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3472
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p3473
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p3474
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3475
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p3476
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/279
p3477
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3478
sa(dp3479
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3480
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p3481
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p3482
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3483
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p3484
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/280
p3485
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3486
sa(dp3487
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3488
sg5
Vhttp://bio2rdf.org/drugbank:DB00715
p3489
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
p3490
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3491
sg23
Nsg24
Nsg25
Nsg26
Vparoxetine
p3492
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/281
p3493
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3494
sa(dp3495
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3496
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p3497
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
p3498
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3499
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p3500
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/282
p3501
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3502
sa(dp3503
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3504
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p3505
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p3506
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3507
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p3508
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/283
p3509
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3510
sa(dp3511
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3512
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p3513
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p3514
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3515
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p3516
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/365
p3517
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3518
sa(dp3519
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3520
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p3521
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p3522
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3523
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p3524
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/366
p3525
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3526
sa(dp3527
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3528
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p3529
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p3530
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3531
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p3532
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/367
p3533
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3534
sa(dp3535
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3536
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p3537
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p3538
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3539
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p3540
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/368
p3541
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3542
sa(dp3543
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3544
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p3545
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p3546
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3547
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p3548
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/493
p3549
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3550
sa(dp3551
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3552
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p3553
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p3554
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3555
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p3556
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/494
p3557
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3558
sa(dp3559
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3560
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p3561
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p3562
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3563
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p3564
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/496
p3565
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3566
sa(dp3567
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3568
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p3569
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p3570
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3571
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p3572
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/497
p3573
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3574
sa(dp3575
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3576
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p3577
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p3578
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3579
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p3580
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/547
p3581
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3582
sa(dp3583
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3584
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p3585
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p3586
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3587
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p3588
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/548
p3589
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3590
sa(dp3591
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3592
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p3593
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p3594
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3595
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p3596
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/550
p3597
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3598
sa(dp3599
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3600
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p3601
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p3602
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3603
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p3604
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/551
p3605
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3606
sa(dp3607
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3608
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p3609
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p3610
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3611
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p3612
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/620
p3613
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3614
sa(dp3615
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3616
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p3617
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p3618
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3619
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p3620
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/621
p3621
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3622
sa(dp3623
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3624
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p3625
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p3626
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3627
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p3628
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/653
p3629
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3630
sa(dp3631
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01012
p3632
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p3633
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vcinacalcet is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p3634
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3635
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p3636
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/654
p3637
sg34
Nsg35
Nsg36
Nsg37
Vcinacalcet
p3638
sa(dp3639
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3640
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p3641
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
p3642
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3643
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p3644
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/684
p3645
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3646
sa(dp3647
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3648
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p3649
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p3650
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3651
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p3652
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/685
p3653
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3654
sa(dp3655
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01149
p3656
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p3657
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vnefazodone is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p3658
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3659
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p3660
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/700
p3661
sg34
Nsg35
Nsg36
Nsg37
Vnefazodone
p3662
sa(dp3663
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3664
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p3665
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
p3666
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3667
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p3668
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/18
p3669
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3670
sa(dp3671
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3672
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p3673
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p3674
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3675
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p3676
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/19
p3677
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3678
sa(dp3679
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3680
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p3681
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p3682
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3683
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p3684
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/20
p3685
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3686
sa(dp3687
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3688
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p3689
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p3690
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3691
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p3692
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/21
p3693
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3694
sa(dp3695
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3696
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p3697
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
p3698
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3699
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p3700
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/129
p3701
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3702
sa(dp3703
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3704
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p3705
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p3706
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3707
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p3708
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/131
p3709
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3710
sa(dp3711
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3712
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p3713
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p3714
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3715
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p3716
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/132
p3717
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3718
sa(dp3719
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3720
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p3721
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p3722
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3723
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p3724
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/133
p3725
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3726
sa(dp3727
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3728
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p3729
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p3730
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3731
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p3732
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/134
p3733
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3734
sa(dp3735
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3736
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p3737
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p3738
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3739
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p3740
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/135
p3741
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3742
sa(dp3743
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3744
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p3745
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
p3746
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3747
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p3748
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/137
p3749
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3750
sa(dp3751
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3752
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p3753
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p3754
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3755
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p3756
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/138
p3757
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3758
sa(dp3759
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3760
sg5
Vhttp://bio2rdf.org/drugbank:DB00472
p3761
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
p3762
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3763
sg23
Nsg24
Nsg25
Nsg26
Vfluoxetine
p3764
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/139
p3765
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3766
sa(dp3767
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3768
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p3769
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p3770
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3771
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p3772
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/140
p3773
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3774
sa(dp3775
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3776
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p3777
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p3778
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3779
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p3780
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/141
p3781
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3782
sa(dp3783
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3784
sg5
Vhttp://bio2rdf.org/drugbank:DB00715
p3785
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
p3786
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3787
sg23
Nsg24
Nsg25
Nsg26
Vparoxetine
p3788
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/142
p3789
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3790
sa(dp3791
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3792
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p3793
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
p3794
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3795
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p3796
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/143
p3797
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3798
sa(dp3799
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3800
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p3801
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p3802
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3803
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p3804
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/268
p3805
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3806
sa(dp3807
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3808
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p3809
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p3810
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3811
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p3812
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/357
p3813
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3814
sa(dp3815
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3816
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p3817
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p3818
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3819
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p3820
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/358
p3821
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3822
sa(dp3823
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3824
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p3825
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p3826
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3827
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p3828
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/359
p3829
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3830
sa(dp3831
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3832
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p3833
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p3834
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3835
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p3836
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/360
p3837
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3838
sa(dp3839
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3840
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p3841
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p3842
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3843
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p3844
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/463
p3845
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3846
sa(dp3847
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3848
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p3849
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p3850
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3851
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p3852
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/464
p3853
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3854
sa(dp3855
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3856
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p3857
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p3858
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3859
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p3860
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/466
p3861
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3862
sa(dp3863
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3864
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p3865
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p3866
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3867
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p3868
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/467
p3869
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3870
sa(dp3871
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3872
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p3873
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p3874
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3875
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p3876
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/468
p3877
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3878
sa(dp3879
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3880
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p3881
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p3882
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3883
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p3884
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/469
p3885
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3886
sa(dp3887
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3888
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p3889
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p3890
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3891
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p3892
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/471
p3893
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3894
sa(dp3895
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3896
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p3897
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p3898
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3899
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p3900
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/472
p3901
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3902
sa(dp3903
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3904
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p3905
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p3906
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3907
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p3908
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/604
p3909
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3910
sa(dp3911
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3912
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p3913
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p3914
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3915
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p3916
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/605
p3917
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3918
sa(dp3919
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3920
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p3921
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p3922
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3923
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p3924
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/607
p3925
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3926
sa(dp3927
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3928
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p3929
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p3930
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p3931
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p3932
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/608
p3933
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3934
sa(dp3935
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3936
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p3937
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
p3938
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3939
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p3940
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/680
p3941
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3942
sa(dp3943
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3944
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p3945
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p3946
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3947
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p3948
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/681
p3949
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3950
sa(dp3951
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00503
p3952
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p3953
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vritonavir is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p3954
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3955
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p3956
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/698
p3957
sg34
Nsg35
Nsg36
Nsg37
Vritonavir
p3958
sa(dp3959
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p3960
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p3961
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
p3962
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p3963
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p3964
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/10
p3965
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p3966
sa(dp3967
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p3968
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p3969
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p3970
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3971
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p3972
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/11
p3973
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p3974
sa(dp3975
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p3976
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p3977
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p3978
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3979
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p3980
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/12
p3981
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p3982
sa(dp3983
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p3984
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p3985
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p3986
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3987
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p3988
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/13
p3989
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p3990
sa(dp3991
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p3992
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p3993
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p3994
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p3995
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p3996
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/65
p3997
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p3998
sa(dp3999
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4000
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p4001
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p4002
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4003
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p4004
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/66
p4005
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4006
sa(dp4007
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4008
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p4009
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
p4010
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p4011
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p4012
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/90
p4013
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4014
sa(dp4015
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4016
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p4017
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p4018
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4019
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p4020
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/92
p4021
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4022
sa(dp4023
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4024
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p4025
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p4026
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4027
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p4028
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/93
p4029
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4030
sa(dp4031
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4032
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p4033
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p4034
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4035
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p4036
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/94
p4037
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4038
sa(dp4039
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4040
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p4041
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p4042
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4043
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p4044
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/95
p4045
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4046
sa(dp4047
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4048
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p4049
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p4050
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4051
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p4052
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/96
p4053
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4054
sa(dp4055
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4056
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p4057
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
p4058
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p4059
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p4060
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/97
p4061
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4062
sa(dp4063
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4064
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p4065
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
p4066
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p4067
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p4068
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/98
p4069
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4070
sa(dp4071
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4072
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p4073
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p4074
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4075
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p4076
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/316
p4077
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4078
sa(dp4079
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4080
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p4081
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p4082
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4083
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p4084
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/319
p4085
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4086
sa(dp4087
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4088
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p4089
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p4090
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4091
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p4092
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/323
p4093
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4094
sa(dp4095
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4096
sg5
Vhttp://bio2rdf.org/drugbank:DB00472
p4097
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
p4098
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4099
sg23
Nsg24
Nsg25
Nsg26
Vfluoxetine
p4100
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/324
p4101
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4102
sa(dp4103
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4104
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p4105
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p4106
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4107
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p4108
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/347
p4109
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4110
sa(dp4111
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4112
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p4113
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p4114
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4115
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p4116
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/348
p4117
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4118
sa(dp4119
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4120
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p4121
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p4122
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4123
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p4124
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/349
p4125
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4126
sa(dp4127
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4128
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p4129
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p4130
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4131
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p4132
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/350
p4133
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4134
sa(dp4135
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4136
sg5
Vhttp://bio2rdf.org/drugbank:DB01098
p4137
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9
p4138
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006120
p4139
sg23
Nsg24
Nsg25
Nsg26
Vrosuvastatin
p4140
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/422
p4141
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4142
sa(dp4143
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4144
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p4145
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p4146
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4147
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p4148
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/438
p4149
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4150
sa(dp4151
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4152
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p4153
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p4154
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4155
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p4156
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/439
p4157
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4158
sa(dp4159
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4160
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p4161
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p4162
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4163
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p4164
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/441
p4165
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4166
sa(dp4167
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4168
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p4169
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p4170
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4171
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p4172
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/442
p4173
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4174
sa(dp4175
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4176
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p4177
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p4178
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4179
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p4180
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/573
p4181
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4182
sa(dp4183
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4184
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p4185
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p4186
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4187
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p4188
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/578
p4189
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4190
sa(dp4191
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4192
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p4193
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p4194
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4195
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p4196
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/591
p4197
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4198
sa(dp4199
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4200
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p4201
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p4202
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4203
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p4204
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/592
p4205
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4206
sa(dp4207
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4208
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p4209
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
p4210
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p4211
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p4212
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/594
p4213
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4214
sa(dp4215
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4216
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p4217
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p4218
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4219
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p4220
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/671
p4221
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4222
sa(dp4223
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4224
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p4225
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
p4226
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p4227
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p4228
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/676
p4229
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4230
sa(dp4231
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4232
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p4233
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p4234
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4235
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p4236
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/677
p4237
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4238
sa(dp4239
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB00661
p4240
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p4241
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vverapamil is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p4242
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4243
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p4244
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/696
p4245
sg34
Nsg35
Nsg36
Nsg37
Vverapamil
p4246
sa(dp4247
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4248
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p4249
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p4250
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4251
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p4252
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/719
p4253
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4254
sa(dp4255
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4256
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p4257
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p4258
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4259
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p4260
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/720
p4261
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4262
sa(dp4263
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4264
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p4265
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p4266
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4267
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p4268
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/67
p4269
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4270
sa(dp4271
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4272
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p4273
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p4274
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4275
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p4276
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/317
p4277
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4278
sa(dp4279
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4280
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p4281
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p4282
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4283
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p4284
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/318
p4285
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4286
sa(dp4287
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4288
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p4289
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p4290
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4291
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p4292
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/320
p4293
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4294
sa(dp4295
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4296
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p4297
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
p4298
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4299
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p4300
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/322
p4301
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4302
sa(dp4303
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4304
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p4305
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p4306
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4307
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p4308
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/325
p4309
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4310
sa(dp4311
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4312
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p4313
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p4314
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4315
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p4316
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/326
p4317
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4318
sa(dp4319
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4320
sg5
Vhttp://bio2rdf.org/drugbank:DB00715
p4321
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
p4322
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4323
sg23
Nsg24
Nsg25
Nsg26
Vparoxetine
p4324
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/327
p4325
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4326
sa(dp4327
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4328
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p4329
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
p4330
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4331
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p4332
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/328
p4333
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4334
sa(dp4335
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4336
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p4337
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p4338
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4339
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p4340
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/329
p4341
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4342
sa(dp4343
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4344
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p4345
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
p4346
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p4347
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p4348
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/330
p4349
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4350
sa(dp4351
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4352
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p4353
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
p4354
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p4355
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p4356
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/331
p4357
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4358
sa(dp4359
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4360
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p4361
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p4362
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4363
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p4364
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/411
p4365
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4366
sa(dp4367
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4368
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p4369
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p4370
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4371
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p4372
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/412
p4373
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4374
sa(dp4375
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4376
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p4377
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p4378
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4379
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p4380
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/413
p4381
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4382
sa(dp4383
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4384
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p4385
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p4386
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4387
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p4388
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/414
p4389
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4390
sa(dp4391
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4392
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p4393
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9
p4394
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006120
p4395
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p4396
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/415
p4397
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4398
sa(dp4399
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4400
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p4401
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p4402
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4403
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p4404
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/572
p4405
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4406
sa(dp4407
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4408
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p4409
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p4410
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4411
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p4412
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/575
p4413
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4414
sa(dp4415
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4416
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p4417
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p4418
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4419
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p4420
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/576
p4421
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4422
sa(dp4423
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4424
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p4425
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p4426
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4427
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p4428
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/577
p4429
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4430
sa(dp4431
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4432
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p4433
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p4434
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4435
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p4436
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/580
p4437
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4438
sa(dp4439
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4440
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p4441
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p4442
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4443
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p4444
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/581
p4445
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4446
sa(dp4447
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4448
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p4449
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p4450
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4451
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p4452
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/667
p4453
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4454
sa(dp4455
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4456
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p4457
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p4458
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4459
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p4460
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/668
p4461
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4462
sa(dp4463
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4464
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p4465
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p4466
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4467
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p4468
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/670
p4469
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4470
sa(dp4471
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01118
p4472
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p4473
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vamiodarone is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
p4474
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p4475
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p4476
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/672
p4477
sg34
Nsg35
Nsg36
Nsg37
Vamiodarone
p4478
sa(dp4479
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4480
sg5
Vhttp://bio2rdf.org/drugbank:DB00962
p4481
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A4
p4482
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4483
sg23
Nsg24
Nsg25
Nsg26
Vzaleplon
p4484
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/52
p4485
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4486
sa(dp4487
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01182
p4488
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p4489
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vpropafenone is predicted to reduce the clearance of duloxetine by inhibition of CYP1A2
p4490
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p4491
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p4492
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/167
p4493
sg34
Nsg35
Nsg36
Nsg37
Vpropafenone
p4494
sa(dp4495
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01182
p4496
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p4497
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vpropafenone is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A2
p4498
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p4499
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p4500
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/168
p4501
sg34
Nsg35
Nsg36
Nsg37
Vpropafenone
p4502
sa(dp4503
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4504
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p4505
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A4
p4506
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4507
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p4508
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/258
p4509
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4510
sa(dp4511
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01182
p4512
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p4513
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vpropafenone is predicted to reduce the clearance of perphenazine by inhibition of CYP1A2
p4514
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006102
p4515
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p4516
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/616
p4517
sg34
Nsg35
Nsg36
Nsg37
Vpropafenone
p4518
sa(dp4519
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4520
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p4521
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A5
p4522
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p4523
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p4524
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/708
p4525
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4526
sa(dp4527
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4528
sg5
Vhttp://bio2rdf.org/drugbank:DB00404
p4529
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A4
p4530
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4531
sg23
Nsg24
Nsg25
Nsg26
Valprazolam
p4532
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/709
p4533
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4534
sa(dp4535
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4536
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p4537
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A5
p4538
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p4539
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p4540
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/50
p4541
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4542
sa(dp4543
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4544
sg5
Vhttp://bio2rdf.org/drugbank:DB00402
p4545
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A4
p4546
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4547
sg23
Nsg24
Nsg25
Nsg26
Veszopiclone
p4548
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/51
p4549
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4550
sa(dp4551
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4552
sg5
Vhttp://bio2rdf.org/drugbank:DB00425
p4553
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A4
p4554
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4555
sg23
Nsg24
Nsg25
Nsg26
Vzolpidem
p4556
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/53
p4557
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4558
sa(dp4559
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4560
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p4561
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A5
p4562
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006132
p4563
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p4564
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/256
p4565
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4566
sa(dp4567
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4568
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p4569
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A4
p4570
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4571
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p4572
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/259
p4573
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4574
sa(dp4575
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4576
sg5
Vhttp://bio2rdf.org/drugbank:DB01149
p4577
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A4
p4578
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4579
sg23
Nsg24
Nsg25
Nsg26
Vnefazodone
p4580
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/260
p4581
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4582
sa(dp4583
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4584
sg5
Vhttp://bio2rdf.org/drugbank:DB00656
p4585
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of trazodone by inhibition of CYP3A4
p4586
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4587
sg23
Nsg24
Nsg25
Nsg26
Vtrazodone
p4588
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/261
p4589
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4590
sa(dp4591
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4592
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p4593
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A4
p4594
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4595
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p4596
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/262
p4597
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4598
sa(dp4599
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4600
sg5
Vhttp://bio2rdf.org/drugbank:DB01076
p4601
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A4
p4602
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4603
sg23
Nsg24
Nsg25
Nsg26
Vatorvastatin
p4604
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/396
p4605
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4606
sa(dp4607
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4608
sg5
Vhttp://bio2rdf.org/drugbank:DB01095
p4609
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A4
p4610
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4611
sg23
Nsg24
Nsg25
Nsg26
Vfluvastatin
p4612
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/397
p4613
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4614
sa(dp4615
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4616
sg5
Vhttp://bio2rdf.org/drugbank:DB00227
p4617
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A4
p4618
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4619
sg23
Nsg24
Nsg25
Nsg26
Vlovastatin
p4620
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/398
p4621
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4622
sa(dp4623
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4624
sg5
Vhttp://bio2rdf.org/drugbank:DB00641
p4625
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4
p4626
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4627
sg23
Nsg24
Nsg25
Nsg26
Vsimvastatin
p4628
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/399
p4629
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4630
sa(dp4631
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4632
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p4633
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A4
p4634
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4635
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p4636
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/542
p4637
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4638
sa(dp4639
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4640
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p4641
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of clozapine by inhibition of CYP3A4
p4642
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4643
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p4644
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/543
p4645
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4646
sa(dp4647
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4648
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p4649
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of risperidone by inhibition of CYP3A4
p4650
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4651
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p4652
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/545
p4653
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4654
sa(dp4655
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4656
sg5
Vhttp://bio2rdf.org/drugbank:DB00246
p4657
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A4
p4658
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4659
sg23
Nsg24
Nsg25
Nsg26
Vziprasidone
p4660
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/546
p4661
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4662
sa(dp4663
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4664
sg5
Vhttp://bio2rdf.org/drugbank:DB00502
p4665
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A4
p4666
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4667
sg23
Nsg24
Nsg25
Nsg26
Vhaloperidol
p4668
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/649
p4669
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4670
sa(dp4671
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4672
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p4673
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A4
p4674
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4675
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p4676
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/650
p4677
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4678
sa(dp4679
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01211
p4680
sg5
Vhttp://bio2rdf.org/drugbank:DB00897
p4681
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vclarithromycin is predicted to reduce the clearance of triazolam by inhibition of CYP3A4
p4682
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006130
p4683
sg23
Nsg24
Nsg25
Nsg26
Vtriazolam
p4684
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/710
p4685
sg34
Nsg35
Nsg36
Nsg37
Vclarithromycin
p4686
sa(dp4687
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4688
sg5
Vhttp://bio2rdf.org/drugbank:DB00476
p4689
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of duloxetine by inhibition of CYP2D6
p4690
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4691
sg23
Nsg24
Nsg25
Nsg26
Vduloxetine
p4692
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/294
p4693
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4694
sa(dp4695
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4696
sg5
Vhttp://bio2rdf.org/drugbank:DB01175
p4697
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of escitalopram by inhibition of CYP2D6
p4698
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4699
sg23
Nsg24
Nsg25
Nsg26
Vescitalopram
p4700
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/295
p4701
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4702
sa(dp4703
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4704
sg5
Vhttp://bio2rdf.org/drugbank:DB00472
p4705
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D6
p4706
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4707
sg23
Nsg24
Nsg25
Nsg26
Vfluoxetine
p4708
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/296
p4709
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4710
sa(dp4711
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4712
sg5
Vhttp://bio2rdf.org/drugbank:DB00176
p4713
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D6
p4714
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4715
sg23
Nsg24
Nsg25
Nsg26
Vfluvoxamine
p4716
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/297
p4717
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4718
sa(dp4719
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4720
sg5
Vhttp://bio2rdf.org/drugbank:DB00370
p4721
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D6
p4722
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4723
sg23
Nsg24
Nsg25
Nsg26
Vmirtazapine
p4724
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/298
p4725
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4726
sa(dp4727
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4728
sg5
Vhttp://bio2rdf.org/drugbank:DB00715
p4729
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of paroxetine by inhibition of CYP2D6
p4730
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4731
sg23
Nsg24
Nsg25
Nsg26
Vparoxetine
p4732
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/299
p4733
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4734
sa(dp4735
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4736
sg5
Vhttp://bio2rdf.org/drugbank:DB00285
p4737
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D6
p4738
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4739
sg23
Nsg24
Nsg25
Nsg26
Vvenlafaxine
p4740
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/300
p4741
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4742
sa(dp4743
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4744
sg5
Vhttp://bio2rdf.org/drugbank:DB01151
p4745
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of desipramine by inhibition of CYP2D6
p4746
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4747
sg23
Nsg24
Nsg25
Nsg26
Vdesipramine
p4748
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/301
p4749
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4750
sa(dp4751
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4752
sg5
Vhttp://bio2rdf.org/drugbank:DB01238
p4753
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D6
p4754
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4755
sg23
Nsg24
Nsg25
Nsg26
Varipiprazole
p4756
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/557
p4757
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4758
sa(dp4759
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4760
sg5
Vhttp://bio2rdf.org/drugbank:DB00363
p4761
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of clozapine by inhibition of CYP2D6
p4762
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4763
sg23
Nsg24
Nsg25
Nsg26
Vclozapine
p4764
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/558
p4765
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4766
sa(dp4767
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4768
sg5
Vhttp://bio2rdf.org/drugbank:DB00334
p4769
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of olanzapine by inhibition of CYP2D6
p4770
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4771
sg23
Nsg24
Nsg25
Nsg26
Volanzapine
p4772
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/560
p4773
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4774
sa(dp4775
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4776
sg5
Vhttp://bio2rdf.org/drugbank:DB00734
p4777
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of risperidone by inhibition of CYP2D6
p4778
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4779
sg23
Nsg24
Nsg25
Nsg26
Vrisperidone
p4780
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/561
p4781
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4782
sa(dp4783
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4784
sg5
Vhttp://bio2rdf.org/drugbank:DB00850
p4785
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of perphenazine by inhibition of CYP2D6
p4786
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4787
sg23
Nsg24
Nsg25
Nsg26
Vperphenazine
p4788
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/659
p4789
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4790
sa(dp4791
g2
Nsg3
Vhttp://bio2rdf.org/drugbank:DB01156
p4792
sg5
Vhttp://bio2rdf.org/drugbank:DB00679
p4793
sg7
Nsg8
Nsg9
Nsg10
Nsg11
Nsg12
Nsg13
Nsg14
Vbupropion is predicted to reduce the clearance of thioridazine by inhibition of CYP2D6
p4794
sg16
Nsg17
g18
sg19
Nsg20
Nsg21
Vhttp://purl.obolibrary.org/obo/PR_000006121
p4795
sg23
Nsg24
Nsg25
Nsg26
Vthioridazine
p4796
sg28
Nsg29
Nsg30
Nsg31
Nsg32
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/660
p4797
sg34
Nsg35
Nsg36
Nsg37
Vbupropion
p4798
sa.